🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hesham Yasin

Al-Nisour University College

ORCID: 0000-0002-1130-3125
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma”.

The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma

Cancers(2022)10.3390/cancers14153830
N/A
0.442DataRank · unranked
18 citations

Matthew D. Tucker, Landon C. Brown, Hesham Yasin, Kristin Kathleen Ancell, Andrew J. Armstrong +12 more

Obesity diminishes response to PD-1-based immunotherapies in renal cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000725
N/A
0DataRank · unranked
90 citations

Rachael M. Orlandella, Justin T. Gibson, William J. Turbitt, Gal Wald, Lewis J. Thomas +25 more

Association between decline of neutrophil-to-eosinophil ratio (NER) at week 6 after ipilimumab plus nivolumab initiation and improved clinical outcomes in metastatic renal cell carcinoma (mRCC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4527
N/A
0DataRank · unranked
2 citations

Matthew D. Tucker, Landon C. Brown, Hesham Yasin, Kristin Kathleen Ancell, Andrew J. Armstrong +12 more

Association between on-treatment eosinophil dynamics and outcomes in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.364
N/A
0DataRank · unranked
0 citations

Matthew D. Tucker, Hesham Yasin, Kristin Kathleen Ancell, Nancy B. Davis, Scott M. Haake +8 more

Improved overall survival of metastatic cancers in the United States across all age groups in the immunotherapy era: Implications for considering elderly patients (age ≥ 75) for immune checkpoint inhibitors (ICIs).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12039
N/A
0DataRank · unranked
0 citations

Matthew D. Tucker, Hesham Yasin, Xingyi Guo, Xiao‐Ou Shu, Brian I. Rini +1 more